secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0000926617-23-000039
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health Q1 revenue up 26% to $2.3M; OvaSuite volume +29%
----------------------------------------------------------------------

- Product revenue $2.3M (+26% YoY); OvaSuite volume 6,259 units (+29% YoY).
- Cash used in operations $5.7M, down 44% from $10.2M YoY; total cash $7.5M at Mar 31.
- Gross margin 51.4% vs 50.8%; revenue per test $370 (-2%).
- 2H 2023 milestones: OvaWatch serial monitoring test study completion, EndoCheck launch.
- Board approved 1-for-15 reverse stock split; secured up to $22.5M in capital facilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000092661723000039/0000926617-23-000039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000092661723000039/awh-20230511x8k.htm
  HTML page:      https://secwatch.observer/filing/0000926617-23-000039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer